The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

STOK FINANCIAL STATEMENTS

Stoke Therapeutics Inc — balance sheet, income statement and cash flow trends

STOKStoke Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue27.6 M $Gross Profit15.2 M $ · 55%Operating Income-223.4 M $ · -810%Pre-tax Income-209.2 M $ · -758%Net Income to Owners-207.9 M $ · -754%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue27.6 M $-86.2%
Gross Profit15.2 M $-92.4%
Operating Income-223.4 M $-654.5%
EBITDA-206.5 M $-470.4%
Net Income to Owners-207.9 M $-496.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets394 M
  • Equity345.5 M $89%
  • Current Liabilities41.9 M $11%

Key Figures

YoY change
Total Assets394 M $+2.5%
Total Liabilities6.5 M $-86.9%
Total Equity345.5 M $+3.2%
Cash & ST Investments292.8 M $+18.2%
Total Debt——
Net Debt-110 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M0-178 M $Operating7.7 M $Investing181.7 M $Financing11.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-178 M $-389.0%
Capital Expenditures2.7 M $+497.1%
Free Cash Flow-180.7 M $-395.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on STOK

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.